Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Sanofi
02 1Advanz Pharma
03 1Amphastar Pharmaceuticals
04 2Aurobindo Pharma Limited
05 1B. Braun Medical
06 5Baxter Healthcare Corporation
07 1Caplin Point Laboratories Limited
08 2Flagship Biotech International Pvt. Ltd
09 1Fresenius Kabi Austria
10 1Fresenius Kabi USA
11 3GLAND PHARMA LIMITED
12 1Health Biotech
13 11Hikma Pharmaceuticals
14 5Hospira, Inc.
15 1Lunan Pharmaceutical
16 1MARCAN PHARMACEUTICALS INC
17 1Meitheal Pharmaceuticals
18 1Montage Laboratories
19 1Stragen Pharma SA
20 1Viatris
21 1Wockhardt
22 2Woodward Pharma Services
23 1Yangtze River Pharmaceutical Group
01 2Ampoule
02 1Concentrate for Solution for Infusion
03 1INJECTABLE; INJECTION
04 37INJECTABLE;INJECTION
05 1INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING
06 2Injectable; Injection
07 3Injection
08 1Liquid Injection
09 2SOLUTION
10 1SOLUTION FOR INJECTION
01 19DISCN
02 2Generic
03 18RX
04 12Blank
01 1Corotrop
02 18MILRINONE LACTATE
03 3MILRINONE LACTATE IN DEXTROSE 5%
04 12MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
05 2MILRINONE LACTATE IN PLASTIC CONTAINER
06 1MILRINONE LACTATE INJECTION USP
07 1MILRINONE LACTATE INJECTION, USP
08 1Milrinon Abcur
09 1Milrinone Lactate
10 1PRIMACOR
11 4PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
12 6Blank
01 2Canada
02 1China
03 5India
04 2Sweden
05 40USA
06 1Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PRIMACOR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1987-12-31
Application Number : 19436
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-08-09
Application Number : 20343
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-08-09
Application Number : 20343
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-08-09
Application Number : 20343
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-08-09
Application Number : 20343
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : Corotrop
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 1 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-08-02
Application Number : 76013
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Packaging :
Approval Date : 2002-05-28
Application Number : 75834
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Packaging :
Approval Date : 2002-05-28
Application Number : 75834
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-05-28
Application Number : 75936
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Packaging :
Approval Date : 2002-05-28
Application Number : 75510
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-05-28
Application Number : 75530
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-05-28
Application Number : 75660
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : Injectable; Injection
Dosage Strength : EQ 20MG /20ML (1MG/ML)
Packaging :
Approval Date :
Application Number : 75660
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : Injectable; Injection
Dosage Strength : EQ 50MG /50ML (1MG/ML)
Packaging :
Approval Date :
Application Number : 75660
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-05-28
Application Number : 75852
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-05-28
Application Number : 75830
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2002-05-28
Application Number : 75884
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)
Packaging :
Approval Date : 2002-05-28
Application Number : 75885
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
Packaging :
Approval Date : 2002-05-28
Application Number : 75885
Regulatory Info : DISCN
Registration Country : USA
